Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
Next Article Previous Article
- Wyden Statement on Trump Trial Balloon on Executive Actions on Unemployment Benefits, Payroll Tax Cut
- Wyden, Feinstein Lead Senate Democrats to Protect Health Care Freedoms in Court
- Wyden, Brown, Cortez Masto, MomsRising, Workers Call For $600 Weekly Boost to Unemployment Benefits to Be Reinstated
- Wyden Statement on Treasury Department's Carried Interest Regulations
- Wyden Solicits Stories from Frontline Health Care Workers Struggling to Get PPE